0001179110-17-000410.txt : 20170104
0001179110-17-000410.hdr.sgml : 20170104
20170104201835
ACCESSION NUMBER: 0001179110-17-000410
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161230
FILED AS OF DATE: 20170104
DATE AS OF CHANGE: 20170104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc.
CENTRAL INDEX KEY: 0001042074
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943103561
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-293-8800
MAIL ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX, INC.
DATE OF NAME CHANGE: 20090721
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX INC
DATE OF NAME CHANGE: 19970710
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shah Sujal
CENTRAL INDEX KEY: 0001588861
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36500
FILM NUMBER: 17508306
MAIL ADDRESS:
STREET 1: C/O CYMABAY THERAPEUTICS, INC.
STREET 2: 3876 BAY CENTER PLACE
CITY: HAYWARD
STATE: CA
ZIP: 94545
4
1
edgar.xml
FORM 4 -
X0306
4
2016-12-30
0
0001042074
CymaBay Therapeutics, Inc.
CBAY
0001588861
Shah Sujal
C/O CYMABAY THERAPEUTICS, INC.
7999 GATEWAY BLVD., SUITE 130
NEWARK
CA
94560
0
1
0
0
Chief Financial Officer
Employee Stock Option (right to buy)
1.82
2016-12-30
4
A
0
25000
0
A
2016-12-30
2026-07-24
Common Stock
25000
25000
D
On July 25, 2016, the Reporting Person was granted an option to purchase 50,000 shares of common stock of the Issuer. The option vests in two equal installments based on the Issuer's achieving certain milestones. The first milestone was met, resulting in vesting of the option as to 25,000 shares.
/s/ Sujal Shah
2017-01-04